Valeo Pharma (TSX:VPH) Total Liabilities : C$87.37 Mil (As of Jan. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Valeo Pharma Total Liabilities?

Valeo Pharma's Total Liabilities for the quarter that ended in Jan. 2024 was C$87.37 Mil.

Valeo Pharma's quarterly Total Liabilities increased from Jul. 2023 (C$80.58 Mil) to Oct. 2023 (C$81.54 Mil) and increased from Oct. 2023 (C$81.54 Mil) to Jan. 2024 (C$87.37 Mil).

Valeo Pharma's annual Total Liabilities increased from Oct. 2021 (C$18.98 Mil) to Oct. 2022 (C$76.11 Mil) and increased from Oct. 2022 (C$76.11 Mil) to Oct. 2023 (C$81.54 Mil).

Valeo Pharma Total Liabilities Historical Data

The historical data trend for Valeo Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Total Liabilities Chart

Valeo Pharma Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Total Liabilities

Get a 7-Day Free Trial

5.83

7.89

18.98

76.11

81.54

Valeo Pharma Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Total Liabilities	Get a 7-Day Free Trial															71.36	77.53	80.58	81.54	87.37

Valeo Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Valeo Pharma's Total Liabilities for the fiscal year that ended in Oct. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	20.274	+	(60.499	+	0.59199999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.179)
	=	81.54

Total Liabilities	=	Total Assets (A: Oct. 2023 )	-	Total Equity (A: Oct. 2023 )
	=	41.207	-	-40.337
	=	81.54

Valeo Pharma's Total Liabilities for the quarter that ended in Jan. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	51.581	+	(35.008	+	0.60899999999999
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0.168)
	=	87.37

Total Liabilities	=	Total Assets (Q: Jan. 2024 )	-	Total Equity (Q: Jan. 2024 )
	=	40.353	-	-47.013
	=	87.37

Valeo Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Valeo Pharma (TSX:VPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (TSX:VPH) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

VPHIF:USA

Address

16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9

Website

https://www.valeopharma.com

Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.

Executives

Luc Mainville

Senior Officer

Valeo Pharma (TSX:VPH) Headlines

No Headlines